Biologics Spine Top Stories HippoFi is Finalizing Definitive Agreements to Join Forces with Industry Giant to Revolutionize the Spinal Biologic Market byJosh SandbergJuly 24, 2023
Biologics Top Stories HippoFi’s PUR Biologics Granted National Approval at the Veterans Health Administration (VHA), the Largest Integrated Healthcare System in the United States byJosh SandbergJune 28, 2023
Biologics Spine Top Stories PUR Biologics Begins Shipment of its Breakthrough Product PURbonedough™ byJosh SandbergMay 9, 2023
Biologics Spine Top Stories PUR Biologics Expands Sales Network by 15% Adding 32 New Distributors byJosh SandbergApril 27, 2023
Biologics Financial Spine Top Stories Goldman Small Cap Research Publishes New Research Report on HippoFi, Inc. byJosh SandbergApril 21, 2023
Biologics Financial Spine Top Stories HippoFi Announces Its Return to a Pink Current Information Tier on the OTC Market byJosh SandbergApril 12, 2023
Biologics Spine Top Stories PUR Biologics Announces Launch of PURcore™, a bioActive Moldable Synthetic for Spine Surgery byJosh SandbergApril 6, 2023
Biologics Financial Spine HippoFi Begins 2023 with Strong Sales of Advanced Biomaterials byJosh SandbergJanuary 13, 2023
Biologics Spine Top Stories HippoFi’s Regenerative Therapeutics Division Launches PURbridge™ for Spine Surgery byChris StewartNovember 23, 2022
Biologics Spine Top Stories HippoFi Signs Strategic Partnership Agreement With Precision Spine, Inc. byChris StewartOctober 5, 2022
